-
sodium (2S,5R,6R)-6-(2-ethoxynaphthalene-1-amido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrate
-
ChemBase ID:
155373
-
Molecular Formular:
C21H23N2NaO6S
-
Molecular Mass:
454.47189
-
Monoisotopic Mass:
454.11745175
-
SMILES and InChIs
SMILES:
CCOc1ccc2ccccc2c1C(=O)N[C@H]1[C@@H]2N(C1=O)[C@H](C(S2)(C)C)C(=O)[O-].O.[Na+]
Canonical SMILES:
CCOc1ccc2c(c1C(=O)N[C@@H]1C(=O)N3[C@@H]1SC([C@@H]3C(=O)[O-])(C)C)cccc2.O.[Na+]
InChI:
InChI=1S/C21H22N2O5S.Na.H2O/c1-4-28-13-10-9-11-7-5-6-8-12(11)14(13)17(24)22-15-18(25)23-16(20(26)27)21(2,3)29-19(15)23;;/h5-10,15-16,19H,4H2,1-3H3,(H,22,24)(H,26,27);;1H2/q;+1;/p-1/t15-,16+,19-;;/m1../s1
InChIKey:
OCXSDHJRMYFTMA-KMFBOIRUSA-M
-
Cite this record
CBID:155373 http://www.chembase.cn/molecule-155373.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
sodium (2S,5R,6R)-6-(2-ethoxynaphthalene-1-amido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate hydrate
|
|
|
IUPAC Traditional name
|
sodium nafcillin(1-) hydrate
|
|
|
Synonyms
|
6-(2-Ethoxy-1-naphthamido)penicillin
|
Nafcillin sodium salt monohydrate
|
|
|
CAS Number
|
|
MDL Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
3.3094113
|
H Acceptors
|
5
|
H Donor
|
1
|
LogD (pH = 5.5)
|
0.11520102
|
LogD (pH = 7.4)
|
-1.1349657
|
Log P
|
2.289126
|
Molar Refractivity
|
118.9755 cm3
|
Polarizability
|
42.997944 Å3
|
Polar Surface Area
|
98.77 Å2
|
Rotatable Bonds
|
5
|
Lipinski's Rule of Five
|
true
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
N3269
|
Application Nafcillin sodium is a narrow-spectrum β-lactam antibiotic. It is used to treat infections caused by Gram-positive bacteria, in particular, species of Staphylococci that are resistant to other penicillins. Nafcillin is used to study penicillin binding proteins (PBPs). It has been used to study penicillin-binding proteins 2a and heterogeneous expression of methicillin resistance in Staphylococcus aureus 1. It is a potential therapy of meningitis due to Staphylococcus aureus.2. Biochem/physiol Actions Nafcillin inhibits bacterial cell wall formation by inhibiting PBPs. The irreversible inhibition of the PBPs prevents the final crosslinking (transpeptidation) of the nascent peptidoglycan layer, which disrupts cell wall synthesis. |
PATENTS
PATENTS
PubChem Patent
Google Patent